April 26, 2018 / 12:59 PM / 3 months ago

BRIEF-Corvus Pharmaceuticals Announces Initiation Of Phase 1/1B Clinical Trial Of CPI-006 In Patients With Advanced Cancer

April 26 (Reuters) - Corvus Pharmaceuticals Inc:

* CORVUS PHARMACEUTICALS ANNOUNCES INITIATION OF PHASE 1/1B CLINICAL TRIAL OF INVESTIGATIONAL ANTI-CD73 ANTIBODY, CPI-006, IN PATIENTS WITH ADVANCED CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below